Articles

The selection of television personality Dr. Mehmet Oz to run the Centers for Medicare and Medicaid Services could bring on budget cuts, the privatization of Medicare and reduced benefits for the nation’s most vulnerable citizens, public-health and government experts say. 

Snowflake’s last three earnings reports spurred negative stock reactions, but investors seem to like the company’s upbeat guidance this time around

GameStop co-founder Gary Kusin sees parallels between Swifties and the videogame retailer’s intensely loyal fans.

Chewy shares charged up to fresh highs for the year on Wednesday, as BofA Securities reversed course to be the most bullish on Wall Street toward the online pet-products retailer, after being the lone bear.

Gold prices have been showing signs of life against a backdrop of worrisome headlines tied to the Russia-Ukraine war — but one analyst said investors should take advantage of pullbacks to buy the metal ahead of a potential climb toward $3,000 an ounce next year.

Another Wall Street firm is increasing its S&P 500 target for next year, with a view that stocks are poised to extend their bull-market run to at least the end of 2025

Qualcomm seems to be preparing for a world without Apple business, but one analyst thinks the company’s PC targets look aggressive.

“The assumption is that if the Fed does what it has to do, it will stand in the way of what Trump wants.”

Two of the U.S. government’s most powerful banking regulators said, in response to pointed questions about their futures from Republicans on the House Financial Services Committee, that they have no plans to step down.

The biotech’s liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.

An analyst cheers the potential for more live programming — and perhaps a stock split next year.

The second Trump administration could be a boon for stock pickers, according to a team of equity strategists at Barclays.